https://www.selleckchem.com/products/WP1130.html
051; medical costs 3,105 US$ vs 4,430 US$, P = .007; CEA 2,431 US$/LY vs 2,902 US$/LY, P = .043). The functional evaluation approach improved long-term clinical outcomes and reduced cumulative medical costs. As a result, the modality composition of functional myocardial ischemia evaluation was demonstrated to offer superior cost-effectiveness in stable CAD. The functional evaluation approach improved long-term clinical outcomes and reduced cumulative medical costs. As a result, the modality composition of functional myocardial ischemia e